Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments ( constrictsblood vessels thereby allev...)

HOME >> MEDICINE >> TECHNOLOGY

Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments

constricts blood vessels, thereby alleviating the symptoms of migraines such as pain, nausea and sensitivity to light and sound.

Although barbiturates and opioids are considered effective for short-term migraine relief, many doctors recommend against prescribing them for long-term use because of the potential for addiction and abuse.

    Physicians responding to the survey said that more of their patients

taking opioids or barbiturates experience drug-related side effects than their

patients taking triptans:


                                    Barbiturates      Opioids         Triptans

    Drowsiness/sleepiness               74 %            84 %             22 %

    Fatigue                             60 %            64 %             13 %

    Confusion                           55 %            70 %             12 %

    Forgetfulness                       52 %            55 %              7 %

    Rebound headaches                   52 %            74 %             24 %

Eighty percent of physicians surveyed said they are "very" or "somewhat" satisfied with the side effects profile of triptans, compared with 17 percent who said the same about opioids and 12 percent who said the same about barbiturates.

The survey found that patients taking triptans are significantly more likely than those taking barbiturates or opioids to report that their medication works well at relieving migraine symptoms, with sixty percent of triptan patients reporting that it describes their medication "extremely" or "very" well to say it relieves their migraines symptoms completely compared with 42 percent of patients taking barbiturates and opioids.

Four out of five patients (82%) have taken more than one prescription medication for their migraines, the survey found. The average number of medications a patient has taken to treat migraines is four.

Patients taking opioids and barbiturates for their migraines also reported a lower quality
'"/>

Page: 1 2 3 4 5 6
Related medicine technology :

1. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
3. NuPathe Reports Positive Phase One Results for NP101 Transdermal Therapy for Acute Migraine
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
6. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
7. Addex Reports Positive Results in Phase IIa Clinical Trial With ADX10059 in Migraine
8. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:

(Date:12/15/2009)... -- Vivakor, Inc. (OTC Bulletin Board: VIVK) ... strong performance in 2009. Vivakor is a ... divisional spokes developing multiple products and technologies ... is anchored to the concept of licensing ... R&D efforts target commercialization and product-specific exit ...

(Date:12/15/2009)... -- Rib-X Pharmaceuticals, Inc., a company focused on ... for the treatment of serious multi-drug-resistant infections announced ... agreement with Massachusetts General Hospital (MGH). ... Dr. David Hooper of MGH will evaluate Rib-X,s ... to determine resistance development and to validate the ...

(Date:12/15/2009)... Dec. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ... in China, announced today,that Weidong Yin, Chairman, ... Central,Television (CCTV) to be one of 18 ... CCTV,s Economic Man-of-the-Year is ... sometimes referred to as the "Oscar Award ...

Breaking Medicine Technology:Vivakor Divisions Continue to Demonstrate Independent Growth 2 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3 Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 2 Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 3 The Law Firm of Kelley 26 Murphy of Philadelphia Blue Bell and Harrisburg has Filed a Law Suit in the United States District Court for the Eastern D 56730 1 The Law Firm of Kelley 26 Murphy of Philadelphia Blue Bell and Harrisburg has Filed a Law Suit in the United States District Court for the Eastern D 56730 2 Innovative Program Educates Hopeful Parents on Third Party Reproduction 56727 1 Innovative Program Educates Hopeful Parents on Third Party Reproduction 56727 2 Innovative Program Educates Hopeful Parents on Third Party Reproduction 56727 3 Sambazon Announces Scientific Advisory Board 56722 1 Sambazon Announces Scientific Advisory Board 56722 2 Sambazon Announces Scientific Advisory Board 56722 3

[0] Vivakor Divisions Continue to Demonstrate Independent Growth [0] Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital [0] Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award

... Response Rate and 100% Disease Control Rate Observed in ... Patients with Medullary Thyroid Cancer, CHICAGO, June ... from an ongoing phase 1 clinical trial of,XL184, a novel small ... The maximum tolerated dose (MTD) for,XL184 has been determined to be ...

... Research Subsidiary HealthCore Presents Data on, Contributing Factors and ... ... INDIANAPOLIS, June 1 HealthCore today,presented a study ... treatment guidelines for newly diagnosed breast,cancer patients at the ...

Other Medicine Technology:Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 2 Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 3 Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 4 Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 5 Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 6 Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women 2 Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women 3

Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO Study Finds Disparities in Breast Cancer Treatment Even Among Fully-Insured African-American and Caucasian Women

(Date:12/15/2009)... USB devices, today launches SafeConsole 4.0, the web management software ... designed to provide better usability for employees and more control ... of licensing options. , ... Washington, ... a leading provider of secure USB devices, today launches SafeConsole ...

(Date:12/15/2009)... within a week of getting news, researchers say ... stress can put newly diagnosed prostate cancer patients ... a new study has found. , Researchers analyzed ... cancer between 1961 and 2004. Of those men, ... a year of cancer diagnosis and 136 (0.08 ...

(Date:12/15/2009)... Accelify is proud to announce the addition ... David will serve as Director of Development in the ... Board of Advisors. ,, David Tokofsky was ... of Education in June 1995. As the Board Member ... 600,000 stretching from Northeast Los Angeles through East Los ...

(Date:12/15/2009)... 15 Virtual Health Technologies, Inc. (OTC ... (a wholly owned operating subsidiary of VHGI) has ... advisory board to assist with bringing the Treasure ... as quickly as possible. Additionally, the company is ... intend to schedule a Live Investor Town Hall ...

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The ... Market Forecasts to 2015, Competitive Benchmarking, ... ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... has released its latest research "The ...

[0] BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices [0] Stress From Prostate Cancer Diagnosis May Be Fatal [0] Accelify Announces the Addition of David Tokofsky to its National Board of Advisors [0] VHGI: VHGI Gold Taps Key Mining Professionals to Assist With Development Plan for $50,000,000 Potential Reserves at Treasure Gulch Gold Mine; Investor Town Hall Meeting to be Scheduled [0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

... of long-term relationships, , , WEDNESDAY, March 25 (HealthDay News) ... long-term relationships transition from a passionate romance to a ... true. , Reporting in the March issue of the ... while the manic, obsessive feelings that come with a ...

... Hispanics, Up 18%, New ASPS Plastic Surgery Statistics ShowARLINGTON ... Tough economic times may have caused a decline in ... patients are up. According to statistics released today by ... procedures increased 11 percent in 2008, with more than ...

... YORK, March 25 An amazing medical discovery that ... (ED) is in the US and looking to make ... News Release, go to: http://www.prnewswire.com/mnr/bathmateus/37601/ Developed by engineers, ... the US at www.bathmateus.com , the Bathmate Hydropump ...

... experience with the Health Insurance Portability and Accountability Act ... document at the doctors office followed by signing a ... there is much more to the law that was ... by using electronic health information while protecting the confidentiality, ...

... high blood pressure or heart disease should avoid consuming energy ... published online Wednesday in the Annals of Pharmacotherapy . ... cans a day of a popular energy drink experienced an ... changes in EKG measurements were reported. , The increases in ...

... , March 25 Trust for America,s Health (TFAH) ... a new report, Keeping America,s Food Safe: A ... U.S. Department of Health and Human Services , which ... and proposes ways to improve the food safety functions ...

Other Medicine News:Health News:Romantic Love Can Last 2 Health News:Romantic Love Can Last 3 Health News:Video: Cosmetic Procedures Up In All Ethnic Groups Except Caucasians In 2008 2 Health News:Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra 2 Health News:Conference on safeguarding health information, May 18-19 2 Health News:Energy drinks may be harmful to people with hypertension, heart disease 2 Health News:New Report Calls Food Safety System Antiquated, Calls for Reform 2 Health News:New Report Calls Food Safety System Antiquated, Calls for Reform 3 Health News:New Report Calls Food Safety System Antiquated, Calls for Reform 4

Romantic Love Can Last Video: Cosmetic Procedures Up In All Ethnic Groups Except Caucasians In 2008 Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra Conference on safeguarding health information, May 18-19 Energy drinks may be harmful to people with hypertension, heart disease New Report Calls Food Safety System Antiquated, Calls for Reform

... GORE-TEX® Stretch Vascular Grafts have ... demanding vascular procedures. Recognized for exceptional ... the endorsement of renowned surgeons worldwide. ... dilatation and the spread of infection, ...

... have met the challenges of the ... exceptional performance and quality, they have ... worldwide. These grafts require no preclotting, ... infection, and ensure utmost thrombectomy safety. ...

... Vascular Grafts have met the challenges ... Recognized for exceptional performance and quality, ... renowned surgeons worldwide. These grafts require ... spread of infection, and ensure utmost ...

... INTERING Vascular Graft, the newest vascular graft ... a leader in vascular surgical products for ... by reducing kinking and compression problems ... new graft provides all of the benefits ...

Medicine Products:

GORE-TEX® Stretch Vascular Grafts-Standard Wall with Removable Rings GORE-TEX Stretch Vascular Grafts-Standard Wall GORE-TEX Bifurcated Stretch Vascular Grafts GORE-TEX INTERING Vascular Graft-Revision Stretch

( constrictsblood vessels thereby allev...)Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments,Health